Clinical trials
Phase 1 Oropharyngeal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 7 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Emory University | 2 |
| Erasmus Medical Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| AstraZeneca | 1 |
| Celldex Therapeutics | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| HRYZ Biotech Co. | 1 |
| Inhibrx Biosciences, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oropharyngeal Neoplasms | 34 |
| Laryngeal Neoplasms | 18 |
| Mouth Neoplasms | 18 |
| Hypopharyngeal Neoplasms | 17 |
| Head and Neck Neoplasms | 16 |
| Squamous Cell Carcinoma of Head and Neck | 15 |
| Carcinoma | 6 |
| Nasopharyngeal Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Carcinoma, Renal Cell | 5 |
Trials
Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.